Tricuspid stenosis pathophysiology

Tricuspid stenosis Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Tricuspid stenosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Tricuspid stenosis pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid stenosis pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tricuspid stenosis pathophysiology
CDC on Tricuspid stenosis pathophysiology
Tricuspid stenosis pathophysiology in the news
Blogs on Tricuspid stenosis pathophysiology
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Tricuspid stenosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pathophysiology

The tricuspid valve leaflets become thickened and sclerotic as the chordae tendineae become shortened. As a result of increased diastolic pressure, right atrial enlargement may be present.